Subscribe

What are you looking for?

Main Menu

明報新聞網

復星醫藥擬投資綠谷醫藥 股價曾跌逾9%

Future Wealths
Future Wealths
16 12 月, 2025
One Min Read
6 Views
0 Comments
復星醫藥(2196)昨晚公布，擬出資14.1億元人民幣控股投資綠谷醫藥，復星醫藥完成後將持股51%。後者開發出中國首個自主開發的阿爾茨海默病治療藥物，但後來卻暫停了該藥物的銷售和生產。

原文: https://finance.mingpao.com/fin/instantf/20251216/1765850970174/%e5%be%a9%e6%98%9f%e9%86%ab%e8%97%a5%e6%93%ac%e6%8a%95%e8%b3%87%e7%b6%a0%e8%b0%b7%e9%86%ab%e8%97%a5-%e8%82%a1%e5%83%b9%e6%9b%be%e8%b7%8c%e9%80%be9

Last Update: 16 12 月, 2025

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept